Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Da Fu

Showing results (341-350 of 375) with videos related to

Pageof 38
Sort By:
Journal of Advanced Research|January 20, 2024
The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancerHao-Yu Tang, Yi-Zhi Cao, Yi-Wei Zhou, et al.
Optics Letters|July 16, 2015
167.75-nm vacuum-ultraviolet ps laser by eighth-harmonic generation of a 1342-nm Nd:YVO4 amplifier in KBBFShi-Bo Dai, Nan Zong, Feng Yang, et al.
Applied Optics|July 21, 2015
8.2  kW high beam quality quasi-continuous-wave face-pumped Nd:YAG slab amplifierZhong-Zheng Chen, Yi-Ting Xu, Ya-Ding Guo, et al.
Journal of Translational Medicine|September 23, 2021
Long non-coding RNA NORAD promotes pancreatic cancer stem cell proliferation and self-renewal by blocking microRNA-202-5p-mediated ANP32E inhibitionYu-Shui Ma, Xiao-Li Yang, Yu-Shan Liu, et al.
Biochemistry and Biophysics Reports|June 17, 2026
Fundamentals and emerging frontiers in p53-targeted drug developmentHui-Deng Long, Ning Zhang, Wen-Er Wang, et al.
Nature Communications|October 19, 2018
Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistanceFei Chen, Qilai Long, Da Fu, et al.
Journal of Advanced Research|May 2, 2026
Artificial intelligence-driven early screening and diagnosis of pancreatic cancer: technical innovations, clinical applications, and precision medicine strategiesYan-Rong Li, Dan Li, Yi-Wei Zhou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 20, 2024
The power and the promise of synthetic lethality for clinical application in cancer treatmentQian-Wen Liu, Zhi-Wen Yang, Qing-Hai Tang, et al.
Molecular Therapy Oncolytics|February 15, 2020
Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with <i>p53</i> DeficiencyYu-Shui Ma, Xiao-Feng Wang, Yun-Jie Zhang, et al.
Cellular Signalling|July 10, 2021
Protein disulfide isomerase inhibits endoplasmic reticulum stress response and apoptosis via its oxidoreductase activity in colorectal cancerYu-Shui Ma, Sun Feng, Lan Lin, et al.
Pageof 38

Showing results (341-350 of 375) with videos related to

Sort By:
Pageof 38
Journal of Advanced Research|January 20, 2024
The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancerHao-Yu Tang, Yi-Zhi Cao, Yi-Wei Zhou, et al.
Optics Letters|July 16, 2015
167.75-nm vacuum-ultraviolet ps laser by eighth-harmonic generation of a 1342-nm Nd:YVO4 amplifier in KBBFShi-Bo Dai, Nan Zong, Feng Yang, et al.
Applied Optics|July 21, 2015
8.2  kW high beam quality quasi-continuous-wave face-pumped Nd:YAG slab amplifierZhong-Zheng Chen, Yi-Ting Xu, Ya-Ding Guo, et al.
Journal of Translational Medicine|September 23, 2021
Long non-coding RNA NORAD promotes pancreatic cancer stem cell proliferation and self-renewal by blocking microRNA-202-5p-mediated ANP32E inhibitionYu-Shui Ma, Xiao-Li Yang, Yu-Shan Liu, et al.
Biochemistry and Biophysics Reports|June 17, 2026
Fundamentals and emerging frontiers in p53-targeted drug developmentHui-Deng Long, Ning Zhang, Wen-Er Wang, et al.
Nature Communications|October 19, 2018
Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistanceFei Chen, Qilai Long, Da Fu, et al.
Journal of Advanced Research|May 2, 2026
Artificial intelligence-driven early screening and diagnosis of pancreatic cancer: technical innovations, clinical applications, and precision medicine strategiesYan-Rong Li, Dan Li, Yi-Wei Zhou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 20, 2024
The power and the promise of synthetic lethality for clinical application in cancer treatmentQian-Wen Liu, Zhi-Wen Yang, Qing-Hai Tang, et al.
Molecular Therapy Oncolytics|February 15, 2020
Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with <i>p53</i> DeficiencyYu-Shui Ma, Xiao-Feng Wang, Yun-Jie Zhang, et al.
Cellular Signalling|July 10, 2021
Protein disulfide isomerase inhibits endoplasmic reticulum stress response and apoptosis via its oxidoreductase activity in colorectal cancerYu-Shui Ma, Sun Feng, Lan Lin, et al.
Pageof 38